Alliance A222001: Oxybutynin Versus Placebo for Hot Flashes in Prostate Cancer Patients on Andro

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 26 Jan 2026. The item focuses on Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer. Review the original article for the full source wording and details.